The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 23, 2019

Filed:

Nov. 04, 2016
Applicant:

Wisconsin Alumni Research Foundation, Madison, WI (US);

Inventors:

Jamey Weichert, Sun Prairie, WI (US);

Anatoly Pinchuk, Fitchburg, WI (US);

Wolfgang Axel Tomé, Ardsley, NY (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 49/00 (2006.01); A61K 51/04 (2006.01); G01N 33/58 (2006.01); C07F 9/10 (2006.01); A61K 41/00 (2006.01); A61K 49/08 (2006.01); A61K 49/10 (2006.01); G01N 33/574 (2006.01); A61N 5/10 (2006.01); G01N 33/60 (2006.01); C07F 9/6515 (2006.01); C07F 9/6524 (2006.01); C07F 9/6561 (2006.01); C07F 9/09 (2006.01); C07F 9/11 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 41/009 (2013.01); A61K 49/085 (2013.01); A61K 49/10 (2013.01); A61K 49/106 (2013.01); A61K 51/0482 (2013.01); A61N 5/1039 (2013.01); A61N 5/1048 (2013.01); A61N 5/1077 (2013.01); C07F 9/091 (2013.01); C07F 9/10 (2013.01); C07F 9/11 (2013.01); C07F 9/6515 (2013.01); C07F 9/6524 (2013.01); C07F 9/6561 (2013.01); G01N 33/574 (2013.01); G01N 33/58 (2013.01); G01N 33/60 (2013.01); A61K 2039/505 (2013.01); A61N 2005/109 (2013.01); G01N 2458/15 (2013.01);
Abstract

Alkylphosphocholine analogs incorporating a chelating moiety that is chelated to gadolinium are disclosed herein. The alkylphophocholine analogs are compounds having the formula: or a salt thereof. Rincludes a chelating agent that is chelated to a gadolinium atom; a is 0 or 1; n is an integer from 12 to 30; m is 0 or 1; Y is —H, —OH, —COOH, —COOX, —OCOX, or —OX, wherein X is an alkyl or an arylalkyl; Ris —NH, —NHZ, —NHZ, or —NZ, wherein each Z is independently an alkyl or an aroalkyl; and b is 1 or 2. The compounds can be used to detect solid tumors or to treat solid tumors. In detection/imaging applications, the gadolinium emits signals that are detectable using magnetic resonance imaging. In therapeutic treatment, the gadolinium emits tumor-targeting charged particles when exposed to epithermal neutrons.


Find Patent Forward Citations

Loading…